WAGNER CHARLES F JR 1223348 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-21 | 2023-11-20 | 2023-11-20 | 4 | Wagner Charles F Jr | EVP & CHIEF FINANCIAL OFFICER | dsp | 3000.0 | 6.04 | 0.12 | 349.88 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 46693.0 | 257.68 (VRTX) |
| 2024-01-04 | 2024-01-02 | 2024-01-02 | 4 | Wagner Charles F Jr | EVP & CHIEF FINANCIAL OFFICER | dsp | 3000.0 | 6.42 | 0.12 | 405.0 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 43693.0 | 257.68 (VRTX) |
| 2024-02-08 | 2024-02-06 | 2024-02-06 to 2024-02-07 | 4 | Wagner Charles F Jr | EVP & CHIEF FINANCIAL OFFICER | acq | 22368.0 | 33.86 | 0.87 | 0.0 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code A | 66061.0
|
257.68 (VRTX) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Wagner Charles F Jr | EVP & CHIEF FINANCIAL OFFICER | dsp | 2607.0 | 3.95 | 0.1 | 422.74 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F | 63454.0 | 257.68 (VRTX) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 to 2024-02-20 | 4 | Wagner Charles F Jr | EVP & CHIEF FINANCIAL OFFICER | dsp | 6562.0 | 10.34 | 0.25 | 422.54 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F | 56892.0
|
258.31 (VRTX) |
| 2024-02-27 | 2024-02-23 | 2024-02-23 | 4 | Wagner Charles F Jr | EVP & CHIEF FINANCIAL OFFICER | dsp | 3309.0 | 5.82 | 0.13 | 431.79 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F | 53583.0 | 258.31 (VRTX) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-22 | 2023-09-20 | 2023-09-20 | 4 | Wagner Charles F Jr | DIRECTOR | acq | 1442.7 | 100 | 0.01 | 0.0 | Direct | Deferred Stock Units | TJX COMPANIES INC /DE/ | code A | 721.35
|
1144.08 (TJX) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)